NCT00646451View on ClinicalTrials.gov

Pregabalin in the Treatment of Essential Tremor

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions
Essential Tremor
Interventions
DRUG

pregabalin (Lyrica)

75 mg bid to 300 mg bid based on per subject tolerability

DRUG

placebo

up to 4 capsules bid as tolerated

Trial Locations (1)

77030

PDCMDC 6550 Fannin, Suite 1801, Houston

Sponsors

Collaborators (1)

Pfizer
All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

Baylor College of Medicine

OTHER

NCT00646451 - Pregabalin in the Treatment of Essential Tremor | Biotech Hunter | Biotech Hunter